Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FD4C6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,112
Award facts
- Contract value 100% obligated
- $15,112.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,112.40 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed price contract represents a non-set-aside procurement action issued on July 14, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion prime vendor agreement running through December 2026 that establishes the company as a critical pharmaceutical supplier for federal military and healthcare system needs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the DLA and Defense Health Agency. The company's federal contracting demonstrates consistent capability in delivering a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Renflexis, a biosimilar medication, exemplifies the type of specialized pharmaceutical commodity the company routinely furnishes through its established federal contract vehicle to support the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FD4C6?
SPE2DB25FD4C6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FD4C6 worth?
The government has obligated $15,112 on SPE2DB25FD4C6.
Is contract SPE2DB25FD4C6 an order under another contract?
Yes. SPE2DB25FD4C6 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD4C6 competed?
The extent of competition for SPE2DB25FD4C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award